Medically underserved populations are significantly affected by hypertension, being 40% more likely to develop the condition and three times more likely to die from heart diseases linked to uncontrol
READ MORE
A study using clinical trial data has identified a higher risk of stroke, heart attack, and hospitalisations for heart failure among older cancer survivors. Published in Cancer, the analysis also...
READ MORE
Out-of-hospital cardiac arrest (OHCA) is a significant cause of mortality, primarily due to shockable rhythms like ventricular fibrillation (VF) and pulseless ventricular tachycardia (pVT). Rapid...
READ MORE
Accurate estimates of the stroke burden, its attributable risks, and global, regional, and national trends are crucial for informed healthcare decision-making, effective prevention strategie
READ MORE
Researchers from the University of Copenhagen have identified lipid biomarkers in children and teens with obesity that indicate an increased risk of developing type 2 diabetes, heart disease
READ MORE
A study conducted at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) in Madrid, Spain, has provided vital insights into how cardiometabolic risk factors and subclinical atherosclerosis
READ MORE
The RESILIENCE clinical trial aims to assess the safety and effectiveness of remote ischaemic conditioning (RIC) in preventing the cardiotoxic effects of anthracycline-based chemotherapy in
READ MORE
A team of researchers at UBC Okanagan has developed a breakthrough heart valve that could be life-changing—and life-saving—for many patients. Working in the Heart Valve Performance Laborator
READ MORE
A new study has identified key factors that influence long-term weight loss in patients with obesity who were prescribed injectable semaglutide or liraglutide for the treatment of type 2 diabetes...
READ MORE
According to preliminary research presented at the American Heart Association’s Hypertension Scientific Sessions 2024 in Chicago, nearly 74% of adults with treatment-resistant high blood pressure...
READ MORE
![Medtronic Secures CE Mark for Innovative Pulmonary Valve Replacement System for Congenital Heart Disease"](https://res.cloudinary.com/healthmanagement-org/image/upload/c_thumb,f_auto,fl_lossy,h_100,q_90,w_100/v1736278991/cw/00129025_cw_image_wi_87dba3e3d5217851f249d0509c004718.webp "Medtronic Secures CE Mark for Innovative Pulmonary Valve Replacement System for Congenital Heart Disease"")
